Evidence map›Paper›PMID 39360529›Full record

ReviewCurrent gene therapy2025

Immune Modulation Strategies in Gene Therapy: Overcoming Immune Barriers and Enhancing Efficacy.

Sivaprakasam Amsaveni, Mahendran Radha, Vidhya Chandrasekaran, Dilip Kumar Chanchal, Sojomon Mathew, Mukesh Chandra Sharma, Jailani Shiekmydeen, Syed Salman Ali

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current gene therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Considerations for early life genetic therapies in cystic fibrosis.American journal of physiology. Lung cellular and molecular physiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sivaprakasam AmsaveniDepartment of Bioinformatics, School of Life Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram 600117, Chennai, Tamilnadu, India.ORCID 0000-0001-9063-7141
Mahendran RadhaDepartment of Bioinformatics, School of Life Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram 600117, Chennai, Tamilnadu, India.ORCID 0000-0003-0711-0336
Vidhya ChandrasekaranDepartment of Primary Processing Storage and Handling, NIFTEM-Thanjavur, Thanjavur 613005, Tamil Nadu, India.ORCID 0000-0003-1175-3668
Dilip Kumar ChanchalCollege of Pharmacy, SR Group of Institutions, Ambabai, Jhansi 284419, Uttar Pradesh, India.ORCID 0000-0002-8937-3748
Sojomon MathewDepartment of Zoology, Government College, Kottayam 686013, Kerala, India.ORCID 0000-0002-4442-9875
Mukesh Chandra SharmaSchool of Pharmacy, Devi Ahilya Vishwavidalaya, Indore 452001, Madhya Pradesh, India.ORCID 0000-0003-0222-5273
Jailani ShiekmydeenDepartment of Pharmacy, Annamalai University, Faculty of Engineering and Technology Chidambaram 608001, Tamilnadu, India.ORCID 0000-0002-4869-5839
Syed Salman AliLloyd Institute of Management and Technology, Plot No.-11, Knowledge Park-II, Greater Noida-201306, Uttar Pradesh, India.ORCID 0000-0001-9163-3353

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The immune system presents significant obstacles to gene therapy, which has limited its use in treating many illnesses. New approaches are needed to overcome these problems and improve the effectiveness of gene therapy. This study explores several techniques to immune regulation within gene therapy, a cutting-edge discipline that aims to optimise results by fine-tuning the immune response. We cover new ways to control the immune system and deliver therapeutic genes just where they are needed, including influencing immunological checkpoints, causing immunotolerance, and making smart use of immunomodulatory drugs. In addition, the study provides insight into new developments in the design of less immunogenic gene delivery vectors, which allow for the extension of transgene expression with minimal adverse immune reactions. In order to maximise the efficacy of gene-based therapies, this review analyses these novel approaches and gives a thorough overview of the present state of the art by addressing obstacles and pointing the way toward future developments in immune regulation. Not only does their integration provide new opportunities for the creation of safer and more effective gene treatments, but it also contains the key to overcome current obstacles.

Indexed as

Genetic TherapyImmunomodulationAnimalsGenetic VectorsGene Transfer TechniquesHumansImmune SystemTransgenesgene delivery vectors.Gene therapyimmune checkpointsimmune modulationimmunomodulatory agentsimmunotolerance

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.